{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T19:41:33Z","timestamp":1792611693411,"version":"4.5.0"},"reference-count":323,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T00:00:00Z","timestamp":1623888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>As B cells differentiate into antibody-secreting cells (ASCs), short-lived plasmablasts (SLPBs) are produced by a primary extrafollicular response, followed by the generation of memory B cells and long-lived plasma cells (LLPCs) in germinal centers (GCs). Generation of IgG4 antibodies is T helper type 2 (Th2) and IL-4, -13, and -10-driven and can occur parallel to IgE, in response to chronic stimulation by allergens and helminths. Although IgG4 antibodies are non-crosslinking and have limited ability to mobilize complement and cellular cytotoxicity, when self-tolerance is lost, they can disrupt ligand-receptor binding and cause a wide range of autoimmune disorders including neurological autoimmunity. In myasthenia gravis with predominantly IgG4 autoantibodies against muscle-specific kinase (MuSK),\u00a0it has been observed that one-time CD20<jats:sup>+<\/jats:sup>B cell depletion with rituximab commonly leads to long-term remission and a marked reduction in autoantibody titer, pointing to a short-lived nature of autoantibody-secreting cells. This is also observed in other predominantly IgG4 autoantibody-mediated neurological disorders, such as chronic inflammatory demyelinating polyneuropathy and autoimmune encephalitis with autoantibodies against the Ranvier paranode and juxtaparanode, respectively, and extends beyond neurological autoimmunity as well. Although IgG1 autoantibody-mediated neurological disorders can also respond well to rituximab induction therapy in combination with an autoantibody titer drop, remission tends to be less long-lasting and cases where titers are refractory tend to occur more often than in IgG4 autoimmunity. Moreover, presence of GC-like structures in the thymus of myasthenic patients with predominantly IgG1 autoantibodies against the acetylcholine receptor and in ovarian teratomas of autoimmune encephalitis patients with predominantly IgG1 autoantibodies against the N\u2010methyl\u2010d\u2010aspartate receptor (NMDAR) confers increased the ability to generate LLPCs. Here, we review available information on the short-and long-lived nature of ASCs in IgG1 and IgG4 autoantibody-mediated neurological disorders and highlight common mechanisms as well as differences, all of which can inform therapeutic strategies and personalized medical approaches.<\/jats:p>","DOI":"10.3389\/fimmu.2021.686466","type":"journal-article","created":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T10:20:13Z","timestamp":1623925213000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":67,"title":["Short- and Long-Lived Autoantibody-Secreting Cells in Autoimmune Neurological Disorders"],"prefix":"10.3389","volume":"12","author":[{"given":"C.","family":"Zografou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. G.","family":"Vakrakou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Stathopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,6,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1086907","article-title":"Predominant Autoantibody Production by Early Human B Cell Precursors","volume":"301","author":"Wardemann","year":"2003","journal-title":"Science"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2020.11.006","article-title":"Germinal Center and Extrafollicular B Cell Responses in Vaccination, Immunity, and Autoimmunity","volume":"53","author":"Elsner","year":"2020","journal-title":"Immunity"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2019.03.016","article-title":"B Cell Responses: Cell Interaction Dynamics and Decisions","volume":"177","author":"Cyster","year":"2019","journal-title":"Cell"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/nri3795","article-title":"The Generation of Antibody-Secreting Plasma Cells","volume":"15","author":"Nutt","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/S0952-7915(99)80029-6","article-title":"B Cell Memory and the Long-Lived Plasma Cell","volume":"11","author":"McHeyzer-Williams","year":"1999","journal-title":"Curr Opin Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/nyas.13535","article-title":"Mechanisms Underlying B Cell Immune Dysregulation and Autoantibody Production in MuSK Myasthenia Gravis: B Cell Abnormalities in MuSK Myasthenia Gravis","volume":"1412","author":"Stathopoulos","year":"2018","journal-title":"Ann NY Acad Sci"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00613","article-title":"Long-Lasting Rituximab-Induced Reduction of Specific-But Not Total-IgG4 in MuSK-Positive Myasthenia Gravis","volume":"11","author":"Marino","year":"2020","journal-title":"Front Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2012-303664","article-title":"Long-Term Benefit of Rituximab in MuSK Autoantibody Myasthenia Gravis Patients: Table\u00a01","volume":"84","author":"Keung","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182407982","article-title":"Long-Lasting Treatment Effect of Rituximab in MuSK Myasthenia","volume":"78","author":"Diaz-Manera","year":"2012","journal-title":"Neurology"},{"key":"B10","doi-asserted-by":"publisher","first-page":"21278","DOI":"10.1038\/s41598-020-78272-8","article-title":"Longitudinal Analysis of Total Serum IgE Levels With Allergen Sensitization and Atopic Diseases in Early Childhood","volume":"10","author":"Wong","year":"2020","journal-title":"Sci Rep"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1177\/1756285611411503","article-title":"Response of Patients With Refractory Myasthenia Gravis to Rituximab: A Retrospective Study","volume":"4","author":"Nowak","year":"2011","journal-title":"Ther Adv Neurol Disord"},{"key":"B12","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jneuroim.2017.05.021","article-title":"Responsiveness to Low-Dose Rituximab in Refractory Generalized Myasthenia Gravis","volume":"311","author":"Jing","year":"2017","journal-title":"J Neuroimmunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2016.4190","article-title":"Durability of the Rituximab Response in Acetylcholine Receptor Autoantibody-Positive Myasthenia Gravis","volume":"74","author":"Robeson","year":"2017","journal-title":"JAMA Neurol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2008.04.039","article-title":"Sustained Response to Rituximab in Anti-AChR and Anti-MuSK Positive Myasthenia Gravis Patients","author":"Illa","year":"2008","journal-title":"J Neuroimmunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000004341","article-title":"Rituximab as Treatment for Anti-MuSK Myasthenia Gravis: Multicenter Blinded Prospective Review","volume":"89","author":"Hehir","year":"2017","journal-title":"Neurology"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2018-319410","article-title":"Long-Term Follow-Up of Patients With Myasthenia Gravis Treated With Low-Dose Rituximab","volume":"90","author":"Chan","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2019-322606","article-title":"Rituximab in AChR Subtype of Myasthenia Gravis: Systematic Review","volume":"91","author":"Di Stefano","year":"2020","journal-title":"J Neurol Neurosurg Psychiat"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1111\/ene.14391","article-title":"Efficacy and Safety of Rituximab in Myasthenia Gravis: A French Multicentre Real-Life Study","volume":"27","author":"Dos Santos","year":"2020","journal-title":"Eur J Neurol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/mus.26876","article-title":"Rituximab in Late-Onset Myasthenia Gravis Is Safe and Effective","volume":"62","author":"Sahai","year":"2020","journal-title":"Muscle Nerve"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2020.116690","article-title":"Differential Response to Rituximab in Anti-AChR and Anti-MuSK Positive Myasthenia Gravis Patients: A Single-Center Retrospective Study","volume":"411","author":"Litchman","year":"2020","journal-title":"J Neurol Sci"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1002\/mus.26790","article-title":"Low-Dose Rituximab Every 6\u2009Months for the Treatment of Acetylcholine Receptor-Positive Refractory Generalized Myasthenia Gravis","volume":"61","author":"Lu","year":"2020","journal-title":"Muscle Nerve"},{"key":"B22","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s00415-019-09191-6","article-title":"High Efficacy of Rituximab for Myasthenia Gravis: A Comprehensive Nationwide Study in Austria","volume":"266","author":"Topakian","year":"2019","journal-title":"J Neurol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3233\/JND-180300","article-title":"Efficacy of Rituximab in Refractory Generalized Anti-Achr Myasthenia Gravis","volume":"5","author":"Landon-Cardinal","year":"2018","journal-title":"J Neuromuscul Dis"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/mus.26156","article-title":"Rituximab in Refractory Myasthenia Gravis: Extended Prospective Study Results","volume":"58","author":"Beecher","year":"2018","journal-title":"Muscle Nerve"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1982.tb12563.x","article-title":"Myelin-Associated Glycoprotein Is the Antigen for a Monoclonal IgM in Polyneuropathy","volume":"39","author":"Braun","year":"1982","journal-title":"J Neurochem"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1126\/science.281.5373.96","article-title":"Visualization of Specific B and T Lymphocyte Interactions in the Lymph Node","volume":"281","author":"Garside","year":"1998","journal-title":"Science"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-041015-055531","article-title":"Memory B Cells of Mice and Humans","volume":"35","author":"Weisel","year":"2017","journal-title":"Annu Rev Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/nature06890","article-title":"Rapid Cloning of High-Affinity Human Monoclonal Antibodies Against Influenza Virus","volume":"453","author":"Wrammert","year":"2008","journal-title":"Nature"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2015.06.013","article-title":"Salmonella Infection Drives Promiscuous B Cell Activation Followed by Extrafollicular Affinity Maturation","volume":"43","author":"Di Niro","year":"2015","journal-title":"Immunity"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1103735","article-title":"Delays and Diversions Mark the Development of B Cell Responses to Borrelia Burgdorferi Infection","volume":"188","author":"Hastey","year":"2012","journal-title":"J Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.1.221","article-title":"Differentiation of B Cells in the Nonlymphoid Tissue of the Synovial Membrane of Patients With Rheumatoid Arthritis","volume":"93","author":"Schr\u00f6der","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1126\/science.1073924","article-title":"Evolution of Autoantibody Responses Via Somatic Hypermutation Outside of Germinal Centers","volume":"297","author":"William","year":"2002","journal-title":"Science"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.10.6200","article-title":"Salmonella Induces a Switched Antibody Response Without Germinal Centers That Impedes the Extracellular Spread of Infection","volume":"178","author":"Cunningham","year":"2007","journal-title":"J Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201141762","article-title":"Early B Blasts Acquire a Capacity for Ig Class Switch Recombination That is Lost as They Become Plasmablasts","volume":"41","author":"Marshall","year":"2011","journal-title":"Eur J Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1084\/jem.187.8.1193","article-title":"T Helper 1 (Th1) and Th2 Characteristics Start to Develop During T Cell Priming and Are Associated With an Immediate Ability to Induce Immunoglobulin Class Switching","volume":"187","author":"Toellner","year":"1998","journal-title":"J Exp Med"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1016\/j.immuni.2019.10.004","article-title":"Liver Is a Generative Site for the B Cell Response to Ehrlichia Muris","volume":"51","author":"Trivedi","year":"2019","journal-title":"Immunity"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1300062","article-title":"Winslow Gm. T Cell\u2013Dependent IgM Memory B Cells Generated During Bacterial Infection Are Required for IgG Responses to Antigen Challenge","volume":"191","author":"Yates","year":"2013","journal-title":"J Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(02)00387-4","article-title":"Memory B Cells Without Somatic Hypermutation Are Generated From Bcl6-Deficient B Cells","volume":"17","author":"Toyama","year":"2002","journal-title":"Immunity"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2008.145391","article-title":"Intractable Hiccup and Nausea in Neuromyelitis Optica With Anti-Aquaporin-4 Antibody: A Herald of Acute Exacerbations","volume":"79","author":"Takahashi","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004976","article-title":"Suppression of Long-Lived Humoral Immunity Following Borrelia Burgdorferi Infection","volume":"11","author":"Elsner","year":"2015","journal-title":"PloS Pathog"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0902710","article-title":"Impaired Germinal Center Responses and Suppression of Local IgG Production During Intracellular Bacterial Infection","volume":"184","author":"Racine","year":"2010","journal-title":"J Immunol"},{"key":"B42","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.161.10.5373","article-title":"Antigen Drives Very Low Affinity B Cells to Become Plasmacytes and Enter Germinal Centers","volume":"161","author":"Dal Porto","year":"1998","journal-title":"J Immunol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3153","article-title":"IL-6 as a Keystone Cytokine in Health and Disease","volume":"16","author":"Hunter","year":"2015","journal-title":"Nat Immunol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.176.7.4042","article-title":"Immunization-Induced Perturbation of Human Blood Plasma Cell Pool: Progressive Maturation, Il-6 Responsiveness, and High Prdi-Bf1\/Blimp1 Expression Are Critical Distinctions Between Antigen-Specific and Nonspecific Plasma Cells","volume":"176","author":"Gonz\u00e1lez-Garc\u00eda","year":"2006","journal-title":"J Immunol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.169.8.4213","article-title":"The Role of Bone Marrow-Derived Stromal Cells in the Maintenance of Plasma Cell Longevity","volume":"169","author":"Wols","year":"2002","journal-title":"J Immunol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2019.04.011","article-title":"T Follicular Helper Cell Biology: A Decade of Discovery and Diseases","volume":"50","author":"Crotty","year":"2019","journal-title":"Immunity"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1002\/aja.1001700315","article-title":"Functional Anatomy of Germinal Centers","volume":"170","author":"Nieuwenhuis","year":"1984","journal-title":"Am J Anat"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/nature05573","article-title":"In Vivo Imaging of Germinal Centres Reveals a Dynamic Open Structure","volume":"446","author":"Schwickert","year":"2007","journal-title":"Nature"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2007.04.008","article-title":"Definition of Germinal-Center B Cell Migration In Vivo Reveals Predominant Intrazonal Circulation Patterns","volume":"26","author":"Hauser","year":"2007","journal-title":"Immunity"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-03-415380","article-title":"Identification of Human Germinal Center Light and Dark Zone Cells and Their Relationship to Human B-Cell Lymphomas","volume":"120","author":"Victora","year":"2012","journal-title":"Blood"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/s0092-8674(00)00078-7","article-title":"Class Switch Recombination and Hypermutation Require Activation-Induced Cytidine Deaminase (AID), a Potential RNA Editing Enzyme","volume":"102","author":"Muramatsu","year":"2000","journal-title":"Cell"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20071006","article-title":"Germinal Centers in Human Lymph Nodes Contain Reactivated Memory B Cells","volume":"204","author":"Bende","year":"2007","journal-title":"J Exp Med"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1016\/j.cell.2020.09.063","article-title":"Antibody Affinity Shapes the Choice Between Memory and Germinal Center B Cell Fates","volume":"183","author":"Viant","year":"2020","journal-title":"Cell"},{"key":"B54","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13075-015-0561-1","article-title":"Polychromatic Flow Cytometry in Evaluating Rheumatic Disease Patients","volume":"17","author":"Wei","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1501843","article-title":"Distinctions Among Circulating Antibody-Secreting Cell Populations, Including B-1 Cells, in Human Adult Peripheral Blood","volume":"196","author":"Qu\u00e1ch","year":"2016","journal-title":"J Immunol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-02-555169","article-title":"A Unique Population of IgG-expressing Plasma Cells Lacking CD19 is Enriched in Human Bone Marrow","volume":"125","author":"Mei","year":"2015","journal-title":"Blood"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2015.06.016","article-title":"Long-Lived Plasma Cells Are Contained Within the CD19\u2013CD38hiCD138+ Subset in Human Bone Marrow","volume":"43","author":"Halliley","year":"2015","journal-title":"Immunity"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102646","article-title":"Update on IgG4-mediated Autoimmune Diseases: New Insights and New Family Members","volume":"19","author":"Koneczny","year":"2020","journal-title":"Autoimmun Rev"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00097","article-title":"A New Classification System for IgG4 Autoantibodies","volume":"9","author":"Koneczny","year":"2018","journal-title":"Front Immunol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/nyas.13561","article-title":"IgG4-Mediated Autoimmune Diseases: A Niche of Antibody-Mediated Disorders: IgG4-Mediated Autoimmune Diseases","volume":"1413","author":"Huijbers","year":"2018","journal-title":"Ann NY Acad Sci"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1111\/ene.12758","article-title":"The Expanding Field of IgG4-Mediated Neurological Autoimmune Disorders","volume":"22","author":"Huijbers","year":"2015","journal-title":"Eur J Neurol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s11882-016-0621-x","article-title":"The Developmental History of IgE and IgG4 Antibodies in Relation to Atopy, Eosinophilic Esophagitis, and the Modified Th2 Response","volume":"16","author":"Aalberse","year":"2016","journal-title":"Curr Allergy Asthma Rep"},{"key":"B63","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.130.2.722","article-title":"Serologic Aspects of IgG4 Antibodies. I. Prolonged Immunization Results in an IgG4-Restricted Response","volume":"130","author":"Aalberse","year":"1983","journal-title":"J Immunol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1126\/science.1144603","article-title":"Anti-Inflammatory Activity of Human IgG4 Antibodies by Dynamic Fab Arm Exchange","volume":"317","author":"van der Neut Kolfschoten","year":"2007","journal-title":"Science"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-09-598268","article-title":"Affinity of FVIII-Specific Antibodies Reveals Major Differences Between Neutralizing and Nonneutralizing Antibodies in Humans","volume":"125","author":"Hofbauer","year":"2015","journal-title":"Blood"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-012-9705-0","article-title":"IgG4 Production Against Adalimumab During Long Term Treatment of RA Patients","volume":"32","author":"van Schouwenburg","year":"2012","journal-title":"J Clin Immunol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1177\/1352458512462920","article-title":"Characterization of Anti-Natalizumab Antibodies in Multiple Sclerosis Patients","volume":"19","author":"Lundkvist","year":"2013","journal-title":"Mult Scler"},{"key":"B68","article-title":"Antibodies of Different Human IgG Subclasses Show Distinct Patterns of Affinity Maturation After Immunization With Keyhole Limpet Haemocyanin","volume":"70","author":"Devey","year":"1990","journal-title":"Immunology"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/s0301-4622(01)00220-4","article-title":"Crystallohydrodynamics for Solving the Hydration Problem for Multi-Domain Proteins: Open Physiological Conformations for Human IgG","volume":"93","author":"Carrasco","year":"2001","journal-title":"Biophys Chem"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1529\/biophysj.107.108993","article-title":"Solution Conformation of Wild-Type and Mutant IgG3 and IgG4 Immunoglobulins Using Crystallohydrodynamics: Possible Implications for Complement Activation","volume":"93","author":"Lu","year":"2007","journal-title":"Biophys J"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1042\/BJ20100641","article-title":"Masking of the Fc Region in Human IgG4 by Constrained X-Ray Scattering Modelling: Implications for Antibody Function and Therapy","volume":"432","author":"Abe","year":"2010","journal-title":"Biochem J"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1179\/136485910X12786389891407","article-title":"Induction of Immunoglobulin G4 in Human Filariasis: An Indicator of Immunoregulation","volume":"104","author":"Adjobimey","year":"2010","journal-title":"Ann Trop Med Parasitol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/173.5.1242","article-title":"Antischistosome IgG4 and IgE Responses Are Affected Differentially by Chemotherapy in Children Versus Adults","volume":"173","author":"Grogan","year":"1996","journal-title":"J Infect Dis"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1084\/jem.168.3.853","article-title":"Interleukin 4 Causes Isotype Switching to IgE in T Cell-Stimulated Clonal B Cell Cultures","volume":"168","author":"Lebman","year":"1988","journal-title":"J Exp Med"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/s0161-5890(01)00121-3","article-title":"c-Rel Is a Selective Activator of a Novel IL-4\/CD40 Responsive Element in the Human Ig Gamma4 Germline Promoter","volume":"38","author":"Agresti","year":"2002","journal-title":"Mol Immunol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.8.3730","article-title":"Interleukin 13 Induces Interleukin 4-Independent IgG4 and IgE Synthesis and CD23 Expression by Human B Cells","volume":"90","author":"Punnonen","year":"1993","journal-title":"Proc Natl Acad Sci"},{"key":"B77","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.160.7.3555","article-title":"Ige Versus IgG4 Production Can Be Differentially Regulated by IL-10","volume":"160","author":"Jeannin","year":"1998","journal-title":"J Immunol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2008.01.072","article-title":"Grass Pollen Immunotherapy: IL-10 Induction and Suppression of Late Responses Precedes IgG4 Inhibitory Antibody Activity","volume":"121","author":"Francis","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1055\/s-0036-1584322","article-title":"The Immunobiology of Immunoglobulin G4","volume":"36","author":"Lighaam","year":"2016","journal-title":"Semin Liver Dis"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.2500\/aap.2013.34.3678","article-title":"Total IgE at 6 Months Predicts Remittance or Persistence of Atopic Dermatitis at 14 Months","volume":"34","author":"Kawamoto","year":"2013","journal-title":"Allergy Asthma Proc"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2012.12.1569","article-title":"The Enigma of IgE+ B-Cell Memory in Human Subjects","volume":"131","author":"Davies","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2014.11.002","article-title":"Ige Responses in Mouse and Man and the Persistence of IgE Memory","volume":"36","author":"Gould","year":"2015","journal-title":"Trends Immunol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3038.1993.tb00089.x","article-title":"Appearance of IgE Antibodies to Ingested and Inhaled Allergens During the First 12 Years of Life in Atopic and Non-Atopic Children","volume":"4","author":"Hattevig","year":"1993","journal-title":"Pediatr Allergy Immunol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201948454","article-title":"Divergent Chemokine Receptor Expression and the Consequence for Human IgG4 B\u00a0Cell Responses","volume":"50","author":"Unger","year":"2020","journal-title":"Eur J Immunol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2014.03.034","article-title":"De Novo Oligoclonal Expansions of Circulating Plasmablasts in Active and Relapsing IgG4-Related Disease","volume":"134","author":"Mattoo","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1002\/art.27435","article-title":"Rituximab Therapy Leads to Rapid Decline of Serum IgG4 Levels and Prompt Clinical Improvement in IgG4-Related Systemic Disease","volume":"62","author":"Khosroshahi","year":"2010","journal-title":"Arthritis Rheum"},{"key":"B87","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1186\/s13075-014-0471-7","article-title":"Regulatory T Cells and Control of the Germinal Centre Response","volume":"16","author":"Vanderleyden","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2008.01774.x","article-title":"Distinct Regulation of IgE, IgG4 and IgA by T Regulatory Cells and Toll-Like Receptors","volume":"63","author":"Meiler","year":"2008","journal-title":"Allergy"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200838193","article-title":"Tr1 and Naturally Occurring Regulatory T Cells Induce IgG4 in B Cells Through GITR\/GITR-L Interaction, IL-10 and TGF-Beta","volume":"38","author":"Satoguina","year":"2008","journal-title":"Eur J Immunol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1016\/s1286-4579(02)00014-x","article-title":"Antigen-Specific T Regulatory-1 Cells Are Associated With Immunosuppression in a Chronic Helminth Infection (Onchocerciasis)","volume":"4","author":"Satoguina","year":"2002","journal-title":"Microbes Infect"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.176.10.5839","article-title":"Regulatory T Cell Responses Develop in Parallel to Th Responses and Control the Magnitude and Phenotype of the Th Effector Population","volume":"176","author":"Taylor","year":"2006","journal-title":"J Immunol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1097\/MPA.0b013e3181577553","article-title":"Circulating Na\u00efve and CD4+CD25high Regulatory T Cells in Patients With Autoimmune Pancreatitis","volume":"36","author":"Miyoshi","year":"2008","journal-title":"Pancreas"},{"key":"B93","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1016\/j.jaci.2017.07.024","article-title":"Expansion of Blood IgG 4 + B, T H 2, and Regulatory T Cells in Patients With IgG 4 -Related Disease","volume":"141","author":"Heeringa","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1097\/MPA.0b013e31821fc796","article-title":"Involvement of Inducible Costimulator- and Interleukin 10-Positive Regulatory T Cells in the Development of IgG4-Related Autoimmune Pancreatitis","volume":"40","author":"Kusuda","year":"2011","journal-title":"Pancreas"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2012.09.012","article-title":"Impaired Regulatory Function in Circulating CD4(+)CD25(High)CD127(Low\/-) T Cells in Patients With Myasthenia Gravis","volume":"145","author":"Thiruppathi","year":"2012","journal-title":"Clin Immunol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.177.8.5296","article-title":"Suppression of Experimental Autoimmune Myasthenia Gravis by Granulocyte-Macrophage Colony-Stimulating Factor Is Associated With an Expansion of FoxP3+ Regulatory T Cells","volume":"177","author":"Sheng","year":"2006","journal-title":"J Immunol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1111\/ced.14309","article-title":"Functional Inhibition of Regulatory CD4+CD25+T Cells in Peripheral Blood of Patients With Pemphigus Vulgaris","volume":"45","author":"Su","year":"2020","journal-title":"Clin Exp Dermatol"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01628","article-title":"Regulatory T Cells Suppress Inflammation and Blistering in Pemphigoid Diseases","volume":"8","author":"Bieber","year":"2017","journal-title":"Front Immunol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.16578","article-title":"Lineage Tracing of Human B Cells Reveals the In Vivo Landscape of Human Antibody Class Switching","volume":"5","author":"Horns","year":"2016","journal-title":"Elife"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2014.05.013","article-title":"Human Responses to Influenza Vaccination Show Seroconversion Signatures and Convergent Antibody Rearrangements","volume":"16","author":"Jackson","year":"2014","journal-title":"Cell Host Microbe"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.2009.03207.x","article-title":"Immunoglobulin G4: An Odd Antibody","volume":"39","author":"Aalberse","year":"2009","journal-title":"Clin Exp Allergy"},{"key":"B102","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/BF02991163","article-title":"IgG4 as a Blocking Antibody","volume":"1","author":"Aalberse","year":"1983","journal-title":"Clin Rev Allergy"},{"key":"B103","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.jaci.2015.07.014","article-title":"Human B-Cell Isotype Switching Origins of Ige","volume":"137","author":"Looney","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1038\/icb.2014.44","article-title":"Human Immunoglobulin Classes and Subclasses Show Variability in VDJ Gene Mutation Levels","volume":"92","author":"Jackson","year":"2014","journal-title":"Immunol Cell Biol"},{"key":"B105","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1111\/j.1365-3083.2011.02525.x","article-title":"Ige Sequences in Individuals Living in an Area of Endemic Parasitism Show Little Mutational Evidence of Antigen Selection","volume":"73","author":"Wang","year":"2011","journal-title":"Scand J Immunol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2014.07.010","article-title":"Influence of Seasonal Exposure to Grass Pollen on Local and Peripheral Blood IgE Repertoires in Patients With Allergic Rhinitis","volume":"134","author":"Wu","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2015.05.029","article-title":"Single B-Cell Deconvolution of Peanut-Specific Antibody Responses in Allergic Patients","volume":"137","author":"Hoh","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2015.09.027","article-title":"Persistence and Evolution of Allergen-Specific IgE Repertoires During Subcutaneous Specific Immunotherapy","volume":"137","author":"Levin","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2018.07.093","article-title":"Autoreactive IgG and Iga B Cells Evolve Through Distinct Subclass Switch Pathways in the Autoimmune Disease Pemphigus Vulgaris","volume":"24","author":"Ellebrecht","year":"2018","journal-title":"Cell Rep"},{"key":"B110","article-title":"Inhibition of Complement Activation by IgG4 Antibodies","volume":"64","author":"van der Zee","year":"1986","journal-title":"Clin Exp Immunol"},{"key":"B111","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1046\/j.0019-2805.2001.01341.x","article-title":"IgG4 Breaking the Rules","volume":"105","author":"Aalberse","year":"2002","journal-title":"Immunology"},{"key":"B112","article-title":"Neuromuscular Junction Disorders","volume-title":"Handbook of Clinical Neurology","author":"Verschuuren","year":"2016"},{"key":"B113","first-page":"377","article-title":"Autoimmune AQP4 Channelopathies and Neuromyelitis Optica Spectrum Disorders","volume-title":"Handbook of Clinical Neurology","author":"Hinson","year":"2016"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1038\/nm1488","article-title":"Self-Antigen Tetramers Discriminate Between Myelin Autoantibodies to Native or Denatured Protein","volume":"13","author":"O\u2019Connor","year":"2007","journal-title":"Nat Med"},{"key":"B115","doi-asserted-by":"publisher","first-page":"e131","DOI":"10.1212\/NXI.0000000000000131","article-title":"Anti-MOG Antibodies Are Frequently Associated With Steroid-Sensitive Recurrent Optic Neuritis","volume":"2","author":"Chalmoukou","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1055\/s-0034-1390394","article-title":"Neuronal Surface Antibody-Mediated Autoimmune Encephalitis","volume":"34","author":"Linnoila","year":"2014","journal-title":"Semin Neurol"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2008.01.013","article-title":"Clinical Fluctuations in MuSK Myasthenia Gravis Are Related to Antigen-Specific IgG4 Instead of Igg1","volume":"195","author":"Niks","year":"2008","journal-title":"J Neuroimmunol"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1313944110","article-title":"Musk IgG4 Autoantibodies Cause Myasthenia Gravis by Inhibiting Binding Between MuSK and Lrp4","volume":"110","author":"Huijbers","year":"2013","journal-title":"Proc Natl Acad Sci"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20061","article-title":"Detection and Characterization of MuSK Antibodies in Seronegative Myasthenia Gravis","volume":"55","author":"McConville","year":"2004","journal-title":"Ann Neurol"},{"key":"B120","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1471-2377-10-46","article-title":"A Systematic Review of Population Based Epidemiological Studies in Myasthenia Gravis","volume":"10","author":"Carr","year":"2010","journal-title":"BMC Neurol"},{"key":"B121","doi-asserted-by":"publisher","first-page":"e357","DOI":"10.1212\/NXI.0000000000000357","article-title":"IgG-specific Cell-Based Assay Detects Potentially Pathogenic MuSK-Abs in Seronegative MG","volume":"4","author":"Huda","year":"2017","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000339103.08830.86","article-title":"HLA Class II Allele Analysis in MuSK-Positive Myasthenia Gravis Suggests a Role for DQ5","volume":"72","author":"Bartoccioni","year":"2009","journal-title":"Neurology"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000218159.79769.5c","article-title":"Strong Association of MuSK Antibody-Positive Myasthenia Gravis and HLA-DR14-DQ5","volume":"66","author":"Niks","year":"2006","journal-title":"Neurology"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1016\/0165-5728(81)90015-1","article-title":"Binding Properties and Subclass Distribution of Anti-Acetylcholine Receptor Antibodies in Myasthenia Gravis","volume":"1","author":"Lefvert","year":"1981","journal-title":"J Neuroimmunol"},{"key":"B125","article-title":"Acetylcholine Receptor Antibody in Myasthenia Gravis: Predominance of IgG Subclasses 1 and 3","volume":"67","author":"R\u00f8dgaard","year":"1987","journal-title":"Clin Exp Immunol"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awn092","article-title":"IgG1 Antibodies to Acetylcholine Receptors in \u201cSeronegative\u201d Myasthenia Gravis","volume":"131","author":"Leite","year":"2008","journal-title":"Brain"},{"key":"B127","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1136\/jnnp.43.7.590","article-title":"Anti-Acetylcholine Receptor Antibodies","volume":"43","author":"Vincent","year":"1980","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B128","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1177\/039463209801100206","article-title":"Absence of Oligoclonal IgG Bands and Anti-Achr Antibodies in the Cerebrospinal Fluid of Patients With Myasthenia Gravis","volume":"11","author":"Kapinas","year":"1998","journal-title":"Int J Immunopathol Pharmacol"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/541760","article-title":"Association of HLA-DQB1\u221705:02 and DRB1\u221716 Alleles With Late-Onset, Nonthymomatous, AChR-Ab-Positive Myasthenia Gravis","volume":"2012","author":"Testi","year":"2012","journal-title":"Autoimmune Dis"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2004.08.002","article-title":"The Role of Complement in Myasthenia Gravis: Serological Evidence of Complement Consumption In Vivo","volume":"158","author":"Romi","year":"2005","journal-title":"J Neuroimmunol"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1111\/nyas.13522","article-title":"Myasthenia Gravis: The Role of Complement at the Neuromuscular Junction","volume":"1412","author":"Howard","year":"2018","journal-title":"Ann N Y Acad Sci"},{"key":"B132","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1196\/annals.1405.020","article-title":"Myasthenia Gravis Seronegative for Acetylcholine Receptor Antibodies","volume":"1132","author":"Vincent","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000289761.64862.ce","article-title":"Pathogenic Potential of IgG Binding to Water Channel Extracellular Domain in Neuromyelitis Optica","volume":"69","author":"Hinson","year":"2007","journal-title":"Neurology"},{"key":"B134","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1212\/WNL.0000000000011153","article-title":"Worldwide Incidence and Prevalence of Neuromyelitis Optica: A Systematic Review","volume":"96","author":"Papp","year":"2021","journal-title":"Neurology"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24617","article-title":"Epidemiology of Aquaporin-4 Autoimmunity and Neuromyelitis Optica Spectrum: Aquaporin-4-IgG Seroprevalence","volume":"79","author":"Flanagan","year":"2016","journal-title":"Ann Neurol"},{"key":"B136","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/1742-2094-7-52","article-title":"Cerebrospinal Fluid Antibodies to Aquaporin-4 in Neuromyelitis Optica and Related Disorders: Frequency, Origin, and Diagnostic Relevance","volume":"7","author":"Jarius","year":"2010","journal-title":"J Neuroinflamm"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.12084","article-title":"Aquaporin-4 Antibodies (Nmo-IgG) as a Serological Marker of Neuromyelitis Optica: A Critical Review of the Literature: Aquaporin-4 Antibodies as Diagnostic Marker of Neuromyelitis Optica","volume":"23","author":"Jarius","year":"2013","journal-title":"Brain Pathol"},{"key":"B138","first-page":"99","article-title":"Detection of Anti-Aquaporin-4 Antibodies in Neuromyelitis Optica: Current Status of the Assays","volume":"15","author":"Waters","year":"2008","journal-title":"Int MS J"},{"key":"B139","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/s41598-020-80535-3","article-title":"Neuromyelitis Optica Is an HLA Associated Disease Different From Multiple Sclerosis: A Systematic Review With Meta-Analysis","volume":"11","author":"Alvarenga","year":"2021","journal-title":"Sci Rep"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1177\/1352458509350741","article-title":"HLA-DRB Association in Neuromyelitis Optica Is Different From That Observed in Multiple Sclerosis","volume":"16","author":"Brum","year":"2010","journal-title":"Mult Scler"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2014.07.001","article-title":"Complement Activation in Patients With Neuromyelitis Optica","volume":"274","author":"Nytrova","year":"2014","journal-title":"J Neuroimmunol"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1172\/JCI122942","article-title":"Membrane Assembly of Aquaporin-4 Autoantibodies Regulates Classical Complement Activation in Neuromyelitis Optica","volume":"129","author":"Soltys","year":"2019","journal-title":"J Clin Invest"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(13)70076-0","article-title":"Eculizumab in AQP4-IgG-Positive Relapsing Neuromyelitis Optica Spectrum Disorders: An Open-Label Pilot Study","volume":"12","author":"Pittock","year":"2013","journal-title":"Lancet Neurol"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-017-8635-4","article-title":"Clinical Spectrum and IgG Subclass Analysis of Anti-Myelin Oligodendrocyte Glycoprotein Antibody-Associated Syndromes: A Multicenter Study","volume":"264","author":"Mariotto","year":"2017","journal-title":"J Neurol"},{"key":"B145","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41582-018-0112-x","article-title":"Myelin Oligodendrocyte Glycoprotein Antibodies in Neurological Disease","volume":"15","author":"Reindl","year":"2019","journal-title":"Nat Rev Neurol"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25131","article-title":"Autoimmune Encephalitis Epidemiology and a Comparison to Infectious Encephalitis","volume":"83","author":"Dubey","year":"2018","journal-title":"Ann Neurol"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000008479","article-title":"Relevance of Antibodies to Myelin Oligodendrocyte Glycoprotein in CSF of Seronegative Cases","volume":"93","author":"Mariotto","year":"2019","journal-title":"Neurology"},{"key":"B148","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s12974-016-0717-1","article-title":"Mog-IgG in NMO and Related Disorders: A Multicenter Study of 50 Patients. Part 1: Frequency, Syndrome Specificity, Influence of Disease Activity, Long-Term Course, Association With AQP4-IgG, and Origin","volume":"13","author":"Jarius","year":"2016","journal-title":"J Neuroinflamm"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000702","article-title":"HLA Association in MOG-IgG- and AQP4-IgG-Related Disorders of the CNS in the Dutch Population","volume":"7","author":"Bruijstens","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B150","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/1742-2094-8-184","article-title":"Complement Activating Antibodies to Myelin Oligodendrocyte Glycoprotein in Neuromyelitis Optica and Related Disorders","volume":"8","author":"Mader","year":"2011","journal-title":"J Neuroinflamm"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00529","article-title":"Myelin Oligodendrocyte Glycoprotein: Deciphering a Target in Inflammatory Demyelinating Diseases","volume":"8","author":"Peschl","year":"2017","journal-title":"Front Immunol"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(08)70224-2","article-title":"Anti-NMDA-Receptor Encephalitis: Case Series and Analysis of the Effects of Antibodies","volume":"7","author":"Dalmau","year":"2008","journal-title":"Lancet Neurol"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-009-0582-4","article-title":"Evidence for Antibody-Mediated Pathogenesis in Anti-NMDAR Encephalitis Associated With Ovarian Teratoma","volume":"118","author":"T\u00fcz\u00fcn","year":"2009","journal-title":"Acta Neuropathol"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0167-10.2010","article-title":"Cellular and Synaptic Mechanisms of Anti-NMDA Receptor Encephalitis","volume":"30","author":"Hughes","year":"2010","journal-title":"J Neurosci"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awu142","article-title":"Glycine Receptor Antibodies in PERM and Related Syndromes: Characteristics, Clinical Features and Outcomes","volume":"137","author":"Carvajal-Gonz\u00e1lez","year":"2014","journal-title":"Brain"},{"key":"B156","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1097\/WCO.0000000000000351","article-title":"Stiff Person Syndrome and Other Immune-Mediated Movement Disorders - New Insights","volume":"29","author":"Balint","year":"2016","journal-title":"Curr Opin Neurol"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1111\/ejn.13212","article-title":"Neuronal Central Nervous System Syndromes Probably Mediated by Autoantibodies","volume":"43","author":"Chefdeville","year":"2016","journal-title":"Eur J Neurosci"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1111\/epi.12528","article-title":"Investigation of Neuronal Autoantibodies in Two Different Focal Epilepsy Syndromes","volume":"55","author":"Ekizoglu","year":"2014","journal-title":"Epilepsia"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25216","article-title":"Genetic Predisposition in Anti-LGI1 and Anti-NMDA Receptor Encephalitis","volume":"83","author":"Mueller","year":"2018","journal-title":"Ann Neurol"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e318228c136","article-title":"Analysis of Complement and Plasma Cells in the Brain of Patients With Anti-NMDAR Encephalitis","volume":"77","author":"Martinez-Hernandez","year":"2011","journal-title":"Neurology"},{"key":"B161","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/ana.21050","article-title":"Paraneoplastic Anti-N-methyl-D-aspartate Receptor Encephalitis Associated With Ovarian Teratoma","volume":"61","author":"Dalmau","year":"2007","journal-title":"Ann Neurol"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aws082","article-title":"Immunopathology of Autoantibody-Associated Encephalitides: Clues for Pathogenesis","volume":"135","author":"Bien","year":"2012","journal-title":"Brain"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000003887","article-title":"Clinical Manifestations of the Anti-IgLON5 Disease","volume":"88","author":"Gaig","year":"2017","journal-title":"Neurology"},{"key":"B164","doi-asserted-by":"publisher","first-page":"e385","DOI":"10.1212\/NXI.0000000000000385","article-title":"IgLON5 Antibody: Neurological Accompaniments and Outcomes in 20 Patients","volume":"4","author":"Honorat","year":"2017","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2019.01056","article-title":"Anti-IgLON5 Disease: A Case With 11-Year Clinical Course and Review of the Literature","volume":"10","author":"Nissen","year":"2019","journal-title":"Front Neurol"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-016-1591-8","article-title":"Neuropathological Criteria of Anti-IgLON5-related Tauopathy","volume":"132","author":"Gelpi","year":"2016","journal-title":"Acta Neuropathol"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1097\/WCO.0000000000000444","article-title":"Autoimmune Encephalitis With Anti-Leucine-Rich Glioma-Inactivated 1 or Anti-Contactin-Associated Protein-Like 2 Antibodies (Formerly Called Voltage-Gated Potassium Channel-Complex Antibodies)","volume":"30","author":"Bastiaansen","year":"2017","journal-title":"Curr Opin Neurol"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awx323","article-title":"The Importance of Early Immunotherapy in Patients With Faciobrachial Dystonic Seizures","volume":"141","author":"Thompson","year":"2018","journal-title":"Brain"},{"key":"B169","doi-asserted-by":"publisher","first-page":"e669","DOI":"10.1212\/NXI.0000000000000669","article-title":"Intrathecal B-Cell Activation in LGI1 Antibody Encephalitis","volume":"7","author":"Lehmann-Horn","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000002917","article-title":"The Clinical Spectrum of Caspr2 Antibody-Associated Disease","volume":"87","author":"van Sonderen","year":"2016","journal-title":"Neurology"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awy109","article-title":"Distinct HLA Associations of LGI1 and CASPR2-Antibody Diseases","volume":"141","author":"Binks","year":"2018","journal-title":"Brain"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24860","article-title":"Anti-LGI1 Encephalitis Is Associated With Unique HLA Subtypes","volume":"81","author":"Kim","year":"2017","journal-title":"Ann Neurol"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2020.577243","article-title":"Novel Findings of HLA Association With Anti-LGI1 Encephalitis: HLA-DRB1*03:01 and HLA-DQB1*02:01","volume":"344","author":"Hu","year":"2020","journal-title":"J Neuroimmunol"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24858","article-title":"Anti-LGI1 Encephalitis Is Strongly Associated With HLA-DR7 and HLA-DRB4","volume":"81","author":"van Sonderen","year":"2017","journal-title":"Ann Neurol"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000639","article-title":"Antibodies to Neurofascin, contactin-1, and Contactin-Associated Protein 1 in CIDP: Clinical Relevance of IgG Isotype","volume":"7","author":"Cortese","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000817","article-title":"Antiparanodal Antibodies and IgG Subclasses in Acute Autoimmune Neuropathy","volume":"7","author":"Appeltshauser","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1159\/000494291","article-title":"Incidence and Prevalence of Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A Systematic Review and Meta-Analysis","volume":"52","author":"Broers","year":"2019","journal-title":"Neuroepidemiology"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awab014","article-title":"Antibodies to the Caspr1\/Contactin-1 Complex in Chronic Inflammatory Demyelinating Polyradiculoneuropathy","volume":"144","author":"Pascual-Go\u00f1i","year":"2021","journal-title":"Brain"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.331","article-title":"Terminal Complement Activation Is Increased and Associated With Disease Severity in CIDP","volume":"3","author":"Quast","year":"2016","journal-title":"Ann Clin Transl Neurol"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.1002\/ana.23794","article-title":"Antibodies to Contactin-1 in Chronic Inflammatory Demyelinating Polyneuropathy","volume":"73","author":"Querol","year":"2013","journal-title":"Ann Neurol"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2019.116533","article-title":"Human Leukocyte Antigens Class II in CIDP Spectrum Neuropathies","volume":"407","author":"Cotti Piccinelli","year":"2019","journal-title":"J Neurol Sci"},{"key":"B182","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.expneurol.2016.10.006","article-title":"Complement Deposition Induced by Binding of Anti-Contactin-1 Auto-Antibodies Is Modified by Immunoglobulins","volume":"287","author":"Appeltshauser","year":"2017","journal-title":"Exp Neurol"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.248","article-title":"Characterization of IgG4 Anti-Neurofascin 155 Antibody-Positive Polyneuropathy","volume":"2","author":"Ogata","year":"2015","journal-title":"Ann Clin Transl Neurol"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000002418","article-title":"Neurofascin-155 IgG4 in Chronic Inflammatory Demyelinating Polyneuropathy","volume":"86","author":"Devaux","year":"2016","journal-title":"Neurology"},{"key":"B185","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/s12974-017-0996-1","article-title":"Anti-NF155 Chronic Inflammatory Demyelinating Polyradiculoneuropathy Strongly Associates to HLA-DRB15","volume":"14","author":"Martinez-Martinez","year":"2017","journal-title":"J Neuroinflamm"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2019.577139","article-title":"Unique HLA Haplotype Associations in IgG4 Anti-Neurofascin 155 Antibody-Positive Chronic Inflammatory Demyelinating Polyneuropathy","volume":"339","author":"Ogata","year":"2020","journal-title":"J Neuroimmunol"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000001326","article-title":"Antibodies to GABAA Receptor \u03b11 and \u03b32 Subunits: Clinical and Serologic Characterization","volume":"84","author":"Pettingill","year":"2015","journal-title":"Neurology"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(13)70299-0","article-title":"Encephalitis With Refractory Seizures, Status Epilepticus, and Antibodies to the GABAA Receptor: A Case Series, Characterisation of the Antigen, and Analysis of the Effects of Antibodies","volume":"13","author":"Petit-Pedrol","year":"2014","journal-title":"Lancet Neurol"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000003713","article-title":"Investigations in GABAA Receptor Antibody-Associated Encephalitis","volume":"88","author":"Spatola","year":"2017","journal-title":"Neurology"},{"key":"B190","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12883-019-1585-y","article-title":"Clinical Characteristics and Prognostic Analysis of Anti-Gamma-Aminobutyric Acid-B (GABA-B) Receptor Encephalitis in Northeast China","volume":"20","author":"Zhang","year":"2020","journal-title":"BMC Neurol"},{"key":"B191","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S1474-4422(09)70324-2","article-title":"Antibodies to the GABA(B) Receptor in Limbic Encephalitis With Seizures: Case Series and Characterisation of the Antigen","volume":"9","author":"Lancaster","year":"2010","journal-title":"Lancet Neurol"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2019.01030","article-title":"Encephalitis With Antibodies Against the GABAB Receptor: High Mortality and Risk Factors","volume":"10","author":"Lin","year":"2019","journal-title":"Front Neurol"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000001682","article-title":"Encephalitis and AMPA Receptor Antibodies: Novel Findings in a Case Series of 22 Patients","volume":"84","author":"H\u00f6ftberger","year":"2015","journal-title":"Neurology"},{"key":"B194","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/S1474-4422(10)70070-3","article-title":"Complement-Mediated Cytotoxicity of Antibodies to the GABAB Receptor","volume":"9","author":"Batocchi","year":"2010","journal-title":"Lancet Neurol"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000003796","article-title":"DPPX Antibody-Associated Encephalitis: Main Syndrome and Antibody Effects","volume":"88","author":"Hara","year":"2017","journal-title":"Neurology"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000001907","article-title":"Anti-DPPX Encephalitis: Pathogenic Effects of Antibodies on Gut and Brain Neurons","volume":"85","author":"Piepgras","year":"2015","journal-title":"Neurology"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.1002\/ana.23756","article-title":"Encephalitis and Antibodies to Dipeptidyl-Peptidase-Like Protein-6, a Subunit of Kv4.2 Potassium Channels","volume":"73","author":"Boronat","year":"2013","journal-title":"Ann Neurol"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000000991","article-title":"DPPX Potassium Channel Antibody: Frequency, Clinical Accompaniments, and Outcomes in 20 Patients","volume":"83","author":"Tobin","year":"2014","journal-title":"Neurology"},{"key":"B199","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000005614","article-title":"Encephalitis With mGluR5 Antibodies: Symptoms and Antibody Effects","volume":"90","author":"Spatola","year":"2018","journal-title":"Neurology"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182364a44","article-title":"Antibodies to Metabotropic Glutamate Receptor 5 in the Ophelia Syndrome","volume":"77","author":"Lancaster","year":"2011","journal-title":"Neurology"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2016.1585","article-title":"Characterization of a Subtype of Autoimmune Encephalitis With Anti-Contactin-Associated Protein-Like 2 Antibodies in the Cerebrospinal Fluid, Prominent Limbic Symptoms, and Seizures","volume":"73","author":"Joubert","year":"2016","journal-title":"JAMA Neurol"},{"key":"B202","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1002\/ana.25120","article-title":"Mechanisms of Caspr2 Antibodies in Autoimmune Encephalitis and Neuromyotonia","volume":"83","author":"Patterson","year":"2018","journal-title":"Ann Neurol"},{"key":"B203","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2020-323226","article-title":"Anti-CASPR2 Clinical Phenotypes Correlate With HLA and Immunological Features","volume":"91","author":"Mu\u00f1iz-Castrillo","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B204","doi-asserted-by":"publisher","first-page":"e75","DOI":"10.1212\/NXI.0000000000000075","article-title":"Complement-Associated Neuronal Loss in a Patient With CASPR2 Antibody-Associated Encephalitis","volume":"2","author":"K\u00f6rtvelyessy","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B205","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aww189","article-title":"Auto-Antibodies to Contactin-Associated Protein 1 (Caspr) in Two Patients With Painful Inflammatory Neuropathy","volume":"139","author":"Doppler","year":"2016","journal-title":"Brain"},{"key":"B206","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e318227b176","article-title":"Progressive Encephalomyelitis With Rigidity and Myoclonus: Glycine and NMDA Receptor Antibodies","volume":"77","author":"Turner","year":"2011","journal-title":"Neurology"},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.1097\/WCO.0000000000000450","article-title":"Redefining Progressive Encephalomyelitis With Rigidity and Myoclonus After the Discovery of Antibodies to Glycine Receptors","volume":"30","author":"Crisp","year":"2017","journal-title":"Curr Opin Neurol"},{"key":"B208","doi-asserted-by":"publisher","first-page":"e16","DOI":"10.1212\/NXI.0000000000000016","article-title":"Glycine Receptor Antibodies in 2 Cases of New, Adult-Onset Epilepsy","volume":"1","author":"Zuliani","year":"2014","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B209","doi-asserted-by":"publisher","DOI":"10.1002\/ana.21589","article-title":"AMPA Receptor Antibodies in Limbic Encephalitis Alter Synaptic Receptor Location","volume":"65","author":"Lai","year":"2009","journal-title":"Ann Neurol"},{"key":"B210","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181d3e404","article-title":"The Expanding Clinical Profile of Anti-AMPA Receptor Encephalitis","volume":"74","author":"Graus","year":"2010","journal-title":"Neurology"},{"key":"B211","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-018-9153-8","article-title":"Patient Characteristics and Outcome Associations in AMPA Receptor Encephalitis","volume":"266","author":"Laurido-Soto","year":"2019","journal-title":"J Neurol"},{"key":"B212","doi-asserted-by":"publisher","DOI":"10.1172\/JCI36131","article-title":"Patients With Lung Cancer and Paraneoplastic Hu Syndrome Harbor HuD-Specific Type 2 CD8+ T Cells","volume":"119","author":"Roberts","year":"2009","journal-title":"J Clin Invest"},{"key":"B213","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.127167","article-title":"Characterization of Pathogenic Monoclonal Autoantibodies Derived From Muscle-Specific Kinase Myasthenia Gravis Patients","volume":"4","author":"Takata","year":"2019","journal-title":"JCI Insight"},{"key":"B214","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awaa104","article-title":"Distinctive Binding Properties of Human Monoclonal LGI1 Autoantibodies Determine Pathogenic Mechanisms","volume":"143","author":"Ramberger","year":"2020","journal-title":"Brain"},{"key":"B215","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000003173","article-title":"Anti-LGI1 Encephalitis: Clinical Syndrome and Long-Term Follow-Up","volume":"87","author":"van Sonderen","year":"2016","journal-title":"Neurology"},{"key":"B216","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2014.260","article-title":"Autoimmune Antigenic Targets at the Node of Ranvier in Demyelinating Disorders","volume":"11","author":"Stathopoulos","year":"2015","journal-title":"Nat Rev Neurol"},{"key":"B217","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.605214","article-title":"Common Denominators in the Immunobiology of IgG4 Autoimmune Diseases: What Do Glomerulonephritis, Pemphigus Vulgaris, Myasthenia Gravis, Thrombotic Thrombocytopenic Purpura and Autoimmune Encephalitis Have in Common","volume":"11","author":"Koneczny","year":"2021","journal-title":"Front Immunol"},{"key":"B218","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13317-019-0124-6","article-title":"Associations Between HLA and Autoimmune Neurological Diseases With Autoantibodies","volume":"11","author":"Mu\u00f1iz-Castrillo","year":"2020","journal-title":"Autoimmun Highlights"},{"key":"B219","doi-asserted-by":"publisher","DOI":"10.1038\/314537a0","article-title":"Antigen-Specific Interaction Between T and B Cells","volume":"314","author":"Lanzavecchia","year":"1985","journal-title":"Nature"},{"key":"B220","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000605","article-title":"HLA and Microtubule-Associated Protein Tau H1 Haplotype Associations in Anti-IgLON5 Disease","volume":"6","author":"Gaig","year":"2019","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B221","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.35.4.577","article-title":"Acetylcholine Receptor Antibody Production by Bone Marrow Cells in a Patient With Myasthenia Gravis","volume":"35","author":"Fujii","year":"1985","journal-title":"Neurology"},{"key":"B222","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1136\/jnnp.39.1.38","article-title":"Myasthenia Gravis: Clinical and Histological Features in Relation to Thymectomy","volume":"39","author":"Sambrook","year":"1976","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B223","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2013.12.008","article-title":"Clonal Heterogeneity of Thymic B Cells From Early-Onset Myasthenia Gravis Patients With Antibodies Against the Acetylcholine Receptor","volume":"52","author":"Vrolix","year":"2014","journal-title":"J Autoimmun"},{"key":"B224","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.158.4.1919","article-title":"Human Anti-Nicotinic Acetylcholine Receptor Recombinant Fab Fragments Isolated From Thymus-Derived Phage Display Libraries From Myasthenia Gravis Patients Reflect Predominant Specificities in Serum and Block the Action of Pathogenic Serum Antibodies","volume":"158","author":"Graus","year":"1997","journal-title":"J Immunol"},{"key":"B225","first-page":"97","article-title":"Cell Types Required for Anti-Acetylcholine Receptor Antibody Synthesis by Cultured Thymocytes and Blood Lymphocytes in Myasthenia Gravis","volume":"58","author":"Willcox","year":"1984","journal-title":"Clin Exp Immunol"},{"key":"B226","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.94263","article-title":"Autoantibody-Producing Plasmablasts After B Cell Depletion Identified in Muscle-Specific Kinase Myasthenia Gravis","volume":"2","author":"Stathopoulos","year":"2017","journal-title":"JCI Insight"},{"key":"B227","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awn240","article-title":"Antibody to Aquaporin-4 in the Long-Term Course of Neuromyelitis Optica","volume":"131","author":"Jarius","year":"2008","journal-title":"Brain"},{"key":"B228","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182152881","article-title":"Long-Term Follow-Up of Patients With Neuromyelitis Optica After Repeated Therapy With Rituximab","volume":"76","author":"Pellkofer","year":"2011","journal-title":"Neurology"},{"key":"B229","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2011.154","article-title":"Repeated Treatment With Rituximab Based on the Assessment of Peripheral Circulating Memory B Cells in Patients With Relapsing Neuromyelitis Optica Over 2 Years","volume":"68","author":"Kim","year":"2011","journal-title":"Arch Neurol"},{"key":"B230","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1001\/jamaneurol.2013.3071","article-title":"A 5-Year Follow-up of Rituximab Treatment in Patients With Neuromyelitis Optica Spectrum Disorder","volume":"70","author":"Kim","year":"2013","journal-title":"JAMA Neurol"},{"key":"B231","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s00401-017-1682-1","article-title":"Pathogenic Implications of Cerebrospinal Fluid Barrier Pathology in Neuromyelitis Optica","volume":"133","author":"Guo","year":"2017","journal-title":"Acta Neuropathol"},{"key":"B232","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1186\/s12883-019-1580-3","article-title":"Neuromyelitis Optica Spectrum Disorder With Massive Basal Ganglia Involvement: A Case Report","volume":"19","author":"Ohara","year":"2019","journal-title":"BMC Neurol"},{"key":"B233","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1017385108","article-title":"Interleukin 6 Signaling Promotes Anti-Aquaporin 4 Autoantibody Production From Plasmablasts in Neuromyelitis Optica","volume":"108","author":"Chihara","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"B234","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awy010","article-title":"Condition-Dependent Generation of Aquaporin-4 Antibodies From Circulating B Cells in Neuromyelitis Optica","volume":"141","author":"Wilson","year":"2018","journal-title":"Brain"},{"key":"B235","doi-asserted-by":"publisher","DOI":"10.1002\/ana.21802","article-title":"Intrathecal Pathogenic Anti-Aquaporin-4 Antibodies in Early Neuromyelitis Optica","volume":"66","author":"Bennett","year":"2009","journal-title":"Ann Neurol"},{"key":"B236","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25648","article-title":"Comparison of the Response to Rituximab Between Myelin Oligodendrocyte Glycoprotein and Aquaporin-4 Antibody Diseases","volume":"87","author":"Durozard","year":"2020","journal-title":"Ann Neurol"},{"key":"B237","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awaa102","article-title":"Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: An Immunopathological Study","volume":"143","author":"Takai","year":"2020","journal-title":"Brain"},{"key":"B238","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2020.102005","article-title":"Clinical and Immunological Differences Between MOG Associated Disease and Anti AQP4 Antibody-Positive Neuromyelitis Optica Spectrum Disorders: Blood-Brain Barrier Breakdown and Peripheral Plasmablasts","volume":"41","author":"Tanaka","year":"2020","journal-title":"Mult Scler Relat Disord"},{"key":"B239","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2013.09.017","article-title":"Rituximab Ameliorates Anti-N-Methyl-D-Aspartate Receptor Encephalitis by Removal of Short-Lived Plasmablasts","volume":"265","author":"Hachiya","year":"2013","journal-title":"J Neuroimmunol"},{"key":"B240","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-020-00921-7","article-title":"Rituximab and Tocilizumab (T-SIRT) in Anti-NMDAR Encephalitis","volume":"18","author":"Lee","year":"2021","journal-title":"Neurotherapeutics"},{"key":"B241","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.444","article-title":"NMDAR Encephalitis: Passive Transfer From Man to Mouse by a Recombinant Antibody","volume":"4","author":"Malviya","year":"2017","journal-title":"Ann Clin Transl Neurol"},{"key":"B242","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25173","article-title":"N-Methyl-D-Aspartate Receptor Antibody Production From Germinal Center Reactions: Therapeutic Implications","volume":"83","author":"Makuch","year":"2018","journal-title":"Ann Neurol"},{"key":"B243","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aww208","article-title":"Human Cerebrospinal Fluid Monoclonal N -Methyl-D-Aspartate Receptor Autoantibodies Are Sufficient for Encephalitis Pathogenesis","volume":"139","author":"Kreye","year":"2016","journal-title":"Brain"},{"key":"B244","doi-asserted-by":"publisher","first-page":"e651","DOI":"10.1212\/NXI.0000000000000651","article-title":"Anti-IGLON5 Disease: A New Case Without Neuropathologic Evidence of Brainstem Tauopathy","volume":"7","author":"Erro","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B245","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2018.00329","article-title":"Iglon5-Associated Encephalitis With Atypical Brain Magnetic Resonance Imaging and Cerebrospinal Fluid Changes","volume":"9","author":"Montagna","year":"2018","journal-title":"Front Neurol"},{"key":"B246","doi-asserted-by":"publisher","first-page":"S46","DOI":"10.1016\/S0140-6736(15)60361-0","article-title":"The Active Intrathecal B-Cell Response in LGI1-Antibody Encephalitis","volume":"385","author":"Irani","year":"2015","journal-title":"Lancet"},{"key":"B247","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-020-04264-1","article-title":"Aggressive Anti-LGI1 Encephalitis Defeated by One Cycle of Intravenous Rituximab-A Case Report","volume":"41","author":"Markovic","year":"2020","journal-title":"Neurol Sci"},{"key":"B248","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25666","article-title":"Human Cerebrospinal Fluid Monoclonal Lgi1 Autoantibodies Increase Neuronal Excitability","volume":"87","author":"Kornau","year":"2020","journal-title":"Ann Neurol"},{"key":"B249","doi-asserted-by":"publisher","first-page":"e149","DOI":"10.1212\/NXI.0000000000000149","article-title":"Rituximab in Treatment-Resistant CIDP With Antibodies Against Paranodal Proteins","volume":"2","author":"Querol","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B250","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-020-10041-z","article-title":"Antibodies Against the Node of Ranvier: A Real-Life Evaluation of Incidence, Clinical Features and Response to Treatment Based on a Prospective Analysis of 1500 Sera","volume":"267","author":"Delmont","year":"2020","journal-title":"J Neurol"},{"key":"B251","doi-asserted-by":"publisher","DOI":"10.1080\/08998280.2020.1822132","article-title":"Dipeptidyl-Peptidase-Like Protein 6 Encephalitis Treated With Immunotherapy","volume":"34","author":"Ye","year":"2020","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"B252","doi-asserted-by":"publisher","DOI":"10.1111\/ene.12164","article-title":"Dramatic Improvement After Rituximab in a Patient With Paraneoplastic Treatment-Refractory Morvan Syndrome Associated With Anti-CASPR2 Antibodies","volume":"20","author":"Ong","year":"2013","journal-title":"Eur J Neurol"},{"key":"B253","doi-asserted-by":"publisher","DOI":"10.1177\/1756286419847418","article-title":"Autoimmune Encephalitis Associated With Antibodies Against the Metabotropic Glutamate Receptor Type 1: Case Report and Review of the Literature","volume":"12","author":"Christ","year":"2019","journal-title":"Ther Adv Neurol Disord"},{"key":"B254","doi-asserted-by":"publisher","first-page":"e232","DOI":"10.1212\/NXI.0000000000000232","article-title":"Evidence of a Pathogenic Role for CD8 + T Cells in Anti-GABA B Receptor Limbic Encephalitis","volume":"3","author":"Golombeck","year":"2016","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B255","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1206939","article-title":"Rituximab (Monoclonal Anti-CD20 Antibody): Mechanisms of Action and Resistance","volume":"22","author":"Smith","year":"2003","journal-title":"Oncogene"},{"key":"B256","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa032534","article-title":"Efficacy of B-Cell-Targeted Therapy With Rituximab in Patients With Rheumatoid Arthritis","volume":"350","author":"Edwards","year":"2004","journal-title":"N Engl J Med"},{"key":"B257","doi-asserted-by":"publisher","DOI":"10.1002\/mus.24063","article-title":"Prolonged B-Cell Depletion in MuSK Myasthenia Gravis Following Rituximab Treatment: Letters to the Editor","volume":"48","author":"Yi","year":"2013","journal-title":"Muscle Nerve"},{"key":"B258","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2008.178","article-title":"B-Cell Depletion Immunotherapy in Pemphigus: Effects on Cellular and Humoral Immune Responses","volume":"128","author":"Mouquet","year":"2008","journal-title":"J Invest Dermatol"},{"key":"B259","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kel393","article-title":"Repeated B Lymphocyte Depletion With Rituximab in Rheumatoid Arthritis Over 7 Yrs","volume":"46","author":"Popa","year":"2006","journal-title":"Rheumatology"},{"key":"B260","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0966-3274(03)00059-5","article-title":"Anti-CD20 Treatment Depletes B-Cells in Blood and Lymphatic Tissue of Cynomolgus Monkeys","volume":"12","author":"Schr\u00f6der","year":"2003","journal-title":"Transpl Immunol"},{"key":"B261","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ker417","article-title":"Total Serum Immunoglobulin Levels in Patients With RA After Multiple B-Cell Depletion Cycles Based on Rituximab: Relationship With B-Cell Kinetics","volume":"51","author":"De La Torre","year":"2012","journal-title":"Rheumatology"},{"key":"B262","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.564","article-title":"The Impact of Rituximab Infusion Protocol on the Long-Term Outcome in Anti-MuSK Myasthenia Gravis","volume":"5","author":"Cort\u00e9s-Vicente","year":"2018","journal-title":"Ann Clin Transl Neurol"},{"key":"B263","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awg223","article-title":"Clinical Correlates With Anti-MuSK Antibodies in Generalized Seronegative Myasthenia Gravis","volume":"126","author":"Evoli","year":"2003","journal-title":"Brain"},{"key":"B264","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1501339","article-title":"Autoreactive T Cells From Patients With Myasthenia Gravis Are Characterized by Elevated IL-17, Ifn-\u03b3, and GM-CSF and Diminished IL-10 Production","volume":"196","author":"Cao","year":"2016","journal-title":"J Immunol"},{"key":"B265","doi-asserted-by":"publisher","first-page":"e547","DOI":"10.1212\/NXI.0000000000000547","article-title":"MuSK Myasthenia Gravis Monoclonal Antibodies: Valency Dictates Pathogenicity","volume":"6","author":"Huijbers","year":"2019","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B266","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e318248dec1","article-title":"Serologic Diagnosis of NMO: A Multicenter Comparison of Aquaporin-4-IgG Assays","volume":"78","author":"Waters","year":"2012","journal-title":"Neurology"},{"key":"B267","doi-asserted-by":"publisher","DOI":"10.1177\/1352458513510981","article-title":"Contribution of Spinal Cord Biopsy to Diagnosis of Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorder","volume":"20","author":"Ringelstein","year":"2014","journal-title":"Mult Scler"},{"key":"B268","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awab102","article-title":"Staging of Astrocytopathy and Complement Activation in Neuromyelitis Optica Spectrum Disorders","author":"Takai","year":"2021","journal-title":"Brain"},{"key":"B269","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2011.62","article-title":"Neuromyelitis Optica With Extensive Active Brain Involvement: An Autopsy Study","volume":"68","author":"Almekhlafi","year":"2011","journal-title":"Arch Neurol"},{"key":"B270","doi-asserted-by":"publisher","DOI":"10.1080\/25785826.2019.1659476","article-title":"Plasmablasts and Neuroimmunological Disorders","volume":"42","author":"Chihara","year":"2019","journal-title":"Immunol Med"},{"key":"B271","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0083036","article-title":"Plasmablasts as Migratory IgG-Producing Cells in the Pathogenesis of Neuromyelitis Optica","volume":"8","author":"Chihara","year":"2013","journal-title":"PloS One"},{"key":"B272","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.418","article-title":"CNS Aquaporin-4-Specific B Cells Connect With Multiple B-cell Compartments in Neuromyelitis Optica Spectrum Disorder","volume":"4","author":"Kowarik","year":"2017","journal-title":"Ann Clin Transl Neurol"},{"key":"B273","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2013.1246","article-title":"Interleukin 6 Receptor Blockade in Patients With Neuromyelitis Optica Nonresponsive to Anti-CD20 Therapy","volume":"70","author":"Ayzenberg","year":"2013","journal-title":"JAMA Neurol"},{"key":"B274","doi-asserted-by":"publisher","DOI":"10.1007\/s10165-012-0715-9","article-title":"Clinical Improvement in a Patient With Neuromyelitis Optica Following Therapy With the Anti-IL-6 Receptor Monoclonal Antibody Tocilizumab","volume":"23","author":"Araki","year":"2013","journal-title":"Mod Rheumatol"},{"key":"B275","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1801295","article-title":"Autoantibodies Against Neurologic Antigens in Nonneurologic Autoimmunity","volume":"202","author":"Stathopoulos","year":"2019","journal-title":"J Immunol"},{"key":"B276","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25291","article-title":"Pathogenicity of Human Antibodies Against Myelin Oligodendrocyte Glycoprotein: MOG Antibody Pathogenicity","volume":"84","author":"Spadaro","year":"2018","journal-title":"Ann Neurol"},{"key":"B277","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12974-019-1525-1","article-title":"Evaluation of Treatment Response in Adults With Relapsing MOG-Ab-Associated Disease","volume":"16","author":"Cobo-Calvo","year":"2019","journal-title":"J Neuroinflamm"},{"key":"B278","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2020.102251","article-title":"Treatment of MOG-IgG-Associated Disorder With Rituximab: An International Study of 121 Patients","volume":"44","author":"Whittam","year":"2020","journal-title":"Multiple Sclerosis Relat Disord"},{"key":"B279","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s12974-016-0718-0","article-title":"Mog-IgG in NMO and Related Disorders: A Multicenter Study of 50 Patients. Part 2: Epidemiology, Clinical Presentation, Radiological and Laboratory Features, Treatment Responses, and Long-Term Outcome","volume":"13","author":"Jarius","year":"2016","journal-title":"J Neuroinflamm"},{"key":"B280","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awq113","article-title":"N-Methyl-D-Aspartate Antibody Encephalitis: Temporal Progression of Clinical and Paraclinical Observations in a Predominantly Non-Paraneoplastic Disorder of Both Sexes","volume":"133","author":"Irani","year":"2010","journal-title":"Brain"},{"key":"B281","doi-asserted-by":"publisher","DOI":"10.1016\/j.pedneo.2018.10.006","article-title":"Immunotherapy for Anti-NMDA Receptor Encephalitis: Experience From a Single Center in Taiwan","volume":"60","author":"Kong","year":"2019","journal-title":"Pediatr Neonatology"},{"key":"B282","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.606923","article-title":"Efficacy and Safety of Rituximab in Chinese Children With Refractory Anti-NMDAR Encephalitis","volume":"11","author":"Dou","year":"2020","journal-title":"Front Neurol"},{"key":"B283","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000002635","article-title":"Rituximab Treatment for Autoimmune Limbic Encephalitis in an Institutional Cohort","volume":"86","author":"Lee","year":"2016","journal-title":"Neurology"},{"key":"B284","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s40478-019-0693-7","article-title":"Immunopathological Characterization of Ovarian Teratomas Associated With Anti-N-Methyl-D-Aspartate Receptor Encephalitis","volume":"7","author":"Chefdeville","year":"2019","journal-title":"Acta Neuropathol Commun"},{"key":"B285","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25173","article-title":"N-Methyl-D-Aspartate Receptor Antibody Production From Germinal Center Reactions: Therapeutic Implications: NMDAR-Antibody Production From Germinal Centers","volume":"83","author":"Makuch","year":"2018","journal-title":"Ann Neurol"},{"key":"B286","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s12974-016-0689-1","article-title":"Cellular Investigations With Human Antibodies Associated With the Anti-IgLON5 Syndrome","volume":"13","author":"Sabater","year":"2016","journal-title":"J Neuroinflamm"},{"key":"B287","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1002\/mds.25926","article-title":"Friend or Foe? IgLON5 Antibodies in a Novel Tauopathy With Prominent Sleep Movement Disorder, Ataxia, and Chorea","volume":"29","author":"Balint","year":"2014","journal-title":"Mov Disord"},{"key":"B288","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(14)70051-1","article-title":"A Novel Non-Rapid-Eye Movement and Rapid-Eye-Movement Parasomnia With Sleep Breathing Disorder Associated With Antibodies to IgLON5: A Case Series, Characterisation of the Antigen, and Post-Mortem Study","volume":"13","author":"Sabater","year":"2014","journal-title":"Lancet Neurol"},{"key":"B289","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-020-09924-y","article-title":"Early Immunotherapy Is Highly Effective in IgG1\/IgG4 Positive IgLON5 Disease","volume":"267","author":"Gr\u00fcter","year":"2020","journal-title":"J Neurol"},{"key":"B290","doi-asserted-by":"publisher","first-page":"e136","DOI":"10.1212\/NXI.0000000000000136","article-title":"Sleep Disorder, Chorea, and Dementia Associated With IgLON5 Antibodies","volume":"2","author":"Simabukuro","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B291","doi-asserted-by":"publisher","first-page":"e962","DOI":"10.1212\/NXI.0000000000000962","article-title":"Anti-IgLON5 Disease: A New Bulbar-Onset Motor Neuron Mimic Syndrome","volume":"8","author":"Werner","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B292","doi-asserted-by":"publisher","DOI":"10.1111\/ane.13207","article-title":"Response to Immunotherapy in Anti-IgLON5 Disease: A Systematic Review","volume":"141","author":"Cabezudo-Garc\u00eda","year":"2020","journal-title":"Acta Neurol Scand"},{"key":"B293","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1001\/jamaneurol.2014.463","article-title":"Effect of Rituximab in Patients With Leucine-Rich, Glioma-Inactivated 1 Antibody\u2013Associated Encephalopathy","volume":"71","author":"Irani","year":"2014","journal-title":"JAMA Neurol"},{"key":"B294","doi-asserted-by":"publisher","DOI":"10.1097\/NEN.0000000000000063","article-title":"IgG and Complement Deposition and Neuronal Loss in Cats and Humans With Epilepsy and Voltage-Gated Potassium Channel Complex Antibodies","volume":"73","author":"Klang","year":"2014","journal-title":"J Neuropathol Exp Neurol"},{"key":"B295","doi-asserted-by":"publisher","DOI":"10.1172\/JCI140453","article-title":"Altered Glycosylation of IgG4 Promotes Lectin Complement Pathway Activation in Anti-PLA2R1\u2013Associated Membranous Nephropathy","volume":"131","author":"Haddad","year":"2021","journal-title":"J Clin Invest"},{"key":"B296","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/14.4.881","article-title":"Glomerular Deposition of Mannose-Binding Lectin in Human Glomerulonephritis","volume":"14","author":"Lhotta","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"B297","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-016-8790-1","article-title":"IgG4 Anti-Phospholipase A2 Receptor Might Activate Lectin and Alternative Complement Pathway Meanwhile in Idiopathic Membranous Nephropathy: An Inspiration From a Cross-Sectional Study","volume":"64","author":"Yang","year":"2016","journal-title":"Immunol Res"},{"key":"B298","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-009-1439-8","article-title":"Igg Subclasses and Complement Pathway in Segmental and Global Membranous Nephropathy","volume":"25","author":"Segawa","year":"2010","journal-title":"Pediatr Nephrol"},{"key":"B299","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfx235","article-title":"Glomerular Mannose-Binding Lectin Deposition in Intrinsic Antigen-Related Membranous Nephropathy","volume":"33","author":"Hayashi","year":"2018","journal-title":"Nephrol Dial Transplant"},{"key":"B300","doi-asserted-by":"publisher","first-page":"e669","DOI":"10.1212\/NXI.0000000000000669","article-title":"Intrathecal B-Cell Activation in LGI1 Antibody Encephalitis","volume":"7","author":"Lehmann-Horn","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B301","doi-asserted-by":"publisher","DOI":"10.1002\/mus.26010","article-title":"Neurofascin-155 IGG4 Neuropathy: Pathophysiological Insights, Spectrum of Clinical Severity and Response to Treatment","volume":"57","author":"Garg","year":"2018","journal-title":"Muscle Nerve"},{"key":"B302","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2020.116993","article-title":"Therapeutic Considerations in a Case of Progressive Encephalomyelitis With Rigidity and Myoclonus","volume":"416","author":"Gluck","year":"2020","journal-title":"J Neurol Sci"},{"key":"B303","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awz094","article-title":"The Expanded Clinical Spectrum of Anti-GABABR Encephalitis and Added Value of KCTD16 Autoantibodies","volume":"142","author":"van Coevorden-Hameete","year":"2019","journal-title":"Brain"},{"key":"B304","doi-asserted-by":"publisher","first-page":"e552","DOI":"10.1212\/NXI.0000000000000552","article-title":"Gaba A Receptor Autoimmunity: A Multicenter Experience","volume":"6","author":"O\u2019Connor","year":"2019","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B305","doi-asserted-by":"publisher","DOI":"10.1002\/ana.23756","article-title":"Encephalitis and Antibodies to Dipeptidyl-Peptidase-Like protein-6, a Subunit of Kv4.2 Potassium Channels","volume":"73","author":"Boronat","year":"2013","journal-title":"Ann Neurol"},{"key":"B306","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2018-226832","article-title":"Morvan\u2019s Syndrome Treated Successfully With Rituximab and Lacosamide","volume":"12","author":"Sveinsson","year":"2019","journal-title":"BMJ Case Rep"},{"key":"B307","doi-asserted-by":"publisher","DOI":"10.1002\/ana.22297","article-title":"Investigations of Caspr2, an Autoantigen of Encephalitis and Neuromyotonia","volume":"69","author":"Lancaster","year":"2011","journal-title":"Ann Neurol"},{"key":"B308","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000002476","article-title":"Metabotropic Glutamate Receptor Type 1 Autoimmunity: Clinical Features and Treatment Outcomes","volume":"86","author":"Lopez-Chiriboga","year":"2016","journal-title":"Neurology"},{"key":"B309","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa067752","article-title":"A Single Cycle of Rituximab for the Treatment of Severe Pemphigus","volume":"357","author":"Joly","year":"2007","journal-title":"N Engl J Med"},{"key":"B310","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-03-341131","article-title":"A Phase 2 Study of the Safety and Efficacy of Rituximab With Plasma Exchange in Acute Acquired Thrombotic Thrombocytopenic Purpura","volume":"118","author":"Scully","year":"2011","journal-title":"Blood"},{"key":"B311","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2010111125","article-title":"Rituximab-Induced Depletion of Anti-PLA2R Autoantibodies Predicts Response in Membranous Nephropathy","volume":"22","author":"Beck","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"B312","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2010.07.032","article-title":"Rituximab for Treatment-Refractory Pemphigus and Pemphigoid: A Case Series of 17 Patients","volume":"65","author":"Kasperkiewicz","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"B313","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.140.1.91","article-title":"Treatment of Refractory Pemphigus Vulgaris With Rituximab (Anti-Cd20 Monoclonal Antibody)","volume":"140","author":"Dupuy","year":"2004","journal-title":"Arch Dermatol"},{"key":"B314","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)30070-3","article-title":"First-Line Rituximab Combined With Short-Term Prednisone Versus Prednisone Alone for the Treatment of Pemphigus (Ritux 3): A Prospective, Multicentre, Parallel-Group, Open-Label Randomised Trial","volume":"389","author":"Joly","year":"2017","journal-title":"Lancet"},{"key":"B315","doi-asserted-by":"publisher","DOI":"10.1172\/JCI138416","article-title":"Antigen-Specific B Cell Depletion for Precision Therapy of Mucosal Pemphigus Vulgaris","volume":"130","author":"Lee","year":"2020","journal-title":"J Clin Invest"},{"key":"B316","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/572539","article-title":"IgG4-Related Lymphadenopathy","volume":"2012","author":"Sato","year":"2012","journal-title":"Int J Rheumatol"},{"key":"B317","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1001\/jamaneurol.2014.4103","article-title":"A Genome-Wide Association Study of Myasthenia Gravis","volume":"72","author":"Renton","year":"2015","journal-title":"JAMA Neurol"},{"key":"B318","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2018.00226","article-title":"The Genetics of Pemphigus Vulgaris","volume":"5","author":"Vodo","year":"2018","journal-title":"Front Med (Lausanne)"},{"key":"B319","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.311","article-title":"Compromised Fidelity of B-Cell Tolerance Checkpoints in AChR and MuSK Myasthenia Gravis","volume":"3","author":"Lee","year":"2016","journal-title":"Ann Clin Transl Neurol"},{"key":"B320","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awz106","article-title":"Early B Cell Tolerance Defects in Neuromyelitis Optica Favour Anti-AQP4 Autoantibody Production","volume":"142","author":"Cotzomi","year":"2019","journal-title":"Brain"},{"key":"B321","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcaa197","article-title":"Naive B Cells in Neuromyelitis Optica Spectrum Disorders: Impact of Steroid Use and Relapses","volume":"2","author":"Janssen","year":"2020","journal-title":"Brain Commun"},{"key":"B322","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/ana.23651","article-title":"Aquaporin 4-Specific T Cells in Neuromyelitis Optica Exhibit a Th17 Bias and Recognize Clostridium ABC Transporter","volume":"72","author":"Varrin-Doyer","year":"2012","journal-title":"Ann Neurol"},{"key":"B323","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.1998.00086.x","article-title":"Recognition of Desmoglein 3 by Autoreactive T Cells in Pemphigus Vulgaris Patients and Normals","volume":"110","author":"Hertl","year":"1998","journal-title":"J Invest Dermatol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.686466\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,5]],"date-time":"2023-11-05T00:38:00Z","timestamp":1699144680000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.686466\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,17]]},"references-count":323,"alternative-id":["10.3389\/fimmu.2021.686466"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.686466","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,17]]},"article-number":"686466"}}